Innovative technology

Other than our complex generic development business area, we are also engaged in the development of innovative nanocarriers suitable to improve active substances´ solubility, biodistribution, toxicity and stability.

Nanomicelles

Our mission is to enhance lives through innovative and cost-effective pharmaceutical solutions. We are dedicated to researching, developing, and delivering high-quality innovative treatments that address urgent health needs globally. With a focus on collaboration, ethics, and sustainability, we strive to improve patient quality of life and advance medical science, prioritizing safety and well-being in everything we do.

Single-drug cargo

Simultaneous encapsulation

Surface decoration

Oncological drugs

Nanomicelle vehicle for oncological drugs

GM1 Ganglioside nanomicelles can cargo Paclitaxel molecules

Increases the aqueous solubility of paclitaxel 6000 times

Protection of cargo from chemical and physiological degradation

Spontaneously bound to Serum Albumin

Oncological drugs

Chagas Disease

Currently applied to improve pharmacokynetic profile of NCE with proven in-vitro antitripanosomal activity

Ganglioside Nano-micelles

Ganglioside Nano-micelles are formed spontaneously in solution. In their lipophilic inner core are capable to transport oncological drugs.

The unique external structure of gangliosides nano-micelles and their size allow to distribute them in the blood stream. Their peculiar interaction with the immune system produce a reactivation of the NK cells against the tumour cells.